GSK1070806: Clinical Trials

6 trials of GSK1070806, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated, 2 completed, 1 unknown. 6 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 26Terminated 3, Completed 2, Unknown 1
Phase 11Completed 1

Follow GSK1070806: new trials by email Literature Review of GSK1070806 trials Research Report on GSK1070806

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Long-Term Study (AtDvance) to Evaluate GSK1070806 in Atopic Dermatitis.
GSK1070806, Placebo - Dermatitis, Atopic
Phase 2TerminatedGlaxoSmithKline792024-06-052026-06-16
A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic Dermatitis
GSK1070806, Placebo - Dermatitis, Atopic
Phase 2TerminatedGlaxoSmithKline1612023-11-162026-06-03
A Clinical Trial of Antibody GSK1070806 in the Treatment of Patients With Moderate to Severe Crohn's Disease
GSK1070806, Placebo- sodium chloride - Crohn Disease
Phase 1 / Phase 2CompletedUniversity of Birmingham52019-02-202021-04-28
Anti IL-18 (GSK1070806) in Behcet's Disease
GSK1070806 - Behcet's Disease
Phase 2UnknownCambridge University Hospitals NHS Foundation Trust122018-08-012018-05-11
Efficacy, Safety, Tolerability and Pharmacokinetic (PK) Study of GSK1070806 for the Prevention of Delayed Graft Function (DGF) in Adult Subjects After Renal Transplantation
GSK1070806, 1) basiliximab 2) mycophenolate mofetil (MMF) OR azathioprine 3) tacrolimus 4) corticosteroids - Kidney Transplantation (Status Post)
Phase 2TerminatedGlaxoSmithKline72016-08-272019-06-26
Investigate the Efficacy and Safety of GSK1070806 in Obese Subjects With T2DM
GSK1070806, Placebo (saline) - Diabetes Mellitus
Phase 2CompletedGlaxoSmithKline372012-08-012016-11-21

Conditions studied

Dermatitis (2)  ·  Dermatitis, Atopic (2)  ·  Eczema (2)  ·  Immune System Diseases (2)  ·  Behcet Syndrome (1)  ·  Crohn Disease (1)  ·  Delayed Graft Function (1)  ·  Diabetes Mellitus (1)  ·  Obesity (1)  ·  Skin Diseases (1)

Sponsors

GlaxoSmithKline (4)  ·  Cambridge University Hospitals NHS Foundation Trust (1)  ·  University of Birmingham (1)

Countries

Spain (4)  ·  United Kingdom (4)  ·  Argentina (2)  ·  Bulgaria (2)  ·  Canada (2)  ·  China (2)  ·  Czechia (2)  ·  France (2)  ·  Germany (2)  ·  Greece (2)  ·  Japan (2)  ·  Mexico (2)  ·  Panama (2)  ·  Poland (2)  ·  South Korea (2)

Top investigators

Marietta Iacucci, MD,PhD (1)  ·  Rona M Smith, MD MRCP (1)

Results publications

PMID 26930607, PMID 33684160

NIH funding

2023 (2), 2015 (1), 2018 (1)